Akari Therapeutics (AKTX)
NASDAQ: AKTX
· Real-Time Price · USD
0.73
0.07 (11.45%)
At close: Sep 04, 2025, 3:57 PM
0.74
1.99%
After-hours: Sep 04, 2025, 05:57 PM EDT
11.45% (1D)
| Bid | 0.64 |
| Market Cap | 11.9K |
| Revenue (ttm) | 26K |
| Net Income (ttm) | -12.27M |
| EPS (ttm) | -2.58 |
| PE Ratio (ttm) | -0.28 |
| Forward PE | -1.42 |
| Analyst | Buy |
| Ask | 0.78 |
| Volume | 109,104 |
| Avg. Volume (20D) | 44,014 |
| Open | 0.68 |
| Previous Close | 0.66 |
| Day's Range | 0.66 - 0.75 |
| 52-Week Range | 0.57 - 3.85 |
| Beta | 0.23 |
About AKTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AKTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AKTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 days ago
-7.91%
Akari Therapeutics shares are trading lower after ...
Unlock content with
Pro Subscription
5 months ago
+20%
Akari Therapeutics shares are trading higher after the company announced it appointed a new CEO.
